Pharmacological evaluation of HP 370, a potential atypical antipsychotic agent: 1. In vivo profile
- 1 January 1987
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 11 (3-4), 157-168
- https://doi.org/10.1002/ddr.430110303
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Pharmacological evaluation of HP 370, a potential atypical antipsychotic agent: 2. In vitro profileDrug Development Research, 1987
- Tardive dyskinesias and drugsDrug Development Research, 1986
- A social interaction model of anxiety sensitive to acutely administered benzodiazepinesDrug Development Research, 1984
- Differential Effects of Classical and Atypical Antipsychotic Drugs on A9 and A10 Dopamine NeuronsScience, 1983
- SCHIZOPHRENIAThe Lancet, 1982
- Drug evaluation by use of rewarding brain stimulationPharmacology & Therapeutics, 1979
- Acute and chronic haloperidol treatment: Comparison of effects on nigral dopaminergic cell activityLife Sciences, 1978
- Clozapine and the Dopamine Hypothesis of Schizophrenia, a Critical AppraisalPharmacopsychiatry, 1975
- CLOZAPINE AND HALOPERIDOL IN A SINGLE‐BLIND CROSS‐OVER TRIAL: THERAPEUTIC AND BIOCHEMICAL ASPECTS IN THE TREATMENT OF SCHIZOPHRENIAActa Psychiatrica Scandinavica, 1974
- Stimulation of locomotor activity following injection of dopamine into the nucleus accumbensJournal of Pharmacy and Pharmacology, 1973